Page last updated: 2024-08-22

iridium and ER-Negative PR-Negative HER2-Negative Breast Cancer

iridium has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Law, BYK; Leung, CH; Ma, DL; Miao, XM; Mok, SWF; Wang, W; Wong, CY; Wong, VKW; Wu, C; Wu, KJ; Yang, GJ; Zhong, HJ	1

Other Studies

1 other study(ies) available for iridium and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy. Angewandte Chemie (International ed. in English), 2018, 10-01, Volume: 57, Issue:40 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Female; Histones; Humans; Iridium; Mice; Mice, Inbred BALB C; Retinoblastoma-Binding Protein 2; Rhodium; Transplantation, Heterologous; Triple Negative Breast Neoplasms	2018

Article

Year

Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy.

Angewandte Chemie (International ed. in English), 2018, 10-01, Volume: 57, Issue:40

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Female; Histones; Humans; Iridium; Mice; Mice, Inbred BALB C; Retinoblastoma-Binding Protein 2; Rhodium; Transplantation, Heterologous; Triple Negative Breast Neoplasms

2018